Childhood Repeated Antibiotic Use Tied to NHL Risk

Reuters Health reports on an American Journal of Epidemiology article this month - A history of using antibiotics more than 10 times in childhood increases the likelihood of developing non-Hodgkin's lymphoma (NHL) by 80%, according to the largest population-based case-control study to date of NHL risk and medication use.



Dr. Ellen T. Chang of the Northern California Cancer Center and her colleagues also found a marginally increased NHL risk among patients with a high cumulative use of non-steroidal anti-inflammatory drugs, but no association between the disease and any other types of medication.



Given the rising incidence of NHL, Dr. Chang and her team note a number of studies have investigated whether certain medications increase the risk of the disease. But results have been inconclusive, with only strong immunosuppressant use consistently tied to NHL. As a number of medical conditions also may be associated with NHL, they add, the question of whether the drug or the underlying condition is involved has complicated matters further.



The researchers looked at data from the Scandinavian Lymphoma Etiology study, which included 3,055 incident cases of NHL, who were matched with 3,187 healthy controls drawn from Danish and Swedish population registers. The "striking" association between antibiotic use and NHL was seen for all subtypes of the disease. High Non-Steroid Anti-Inflamitory pain relievers (NSAID) use increased overall risk of NHL and of diffuse large B-cell NHL, but did not increase the likelihood of any other disease subtype.



The increasing use of antibiotics in the 20th century could explain the rise in NHL cases, if the drugs are in fact responsible for the association observed, Dr. Chang and her colleagues note. However, they add, their study was unable to determine if antibiotics and NSAIDs affected risk apart from the underlying inflammation, infections or susceptibility to infection.



"Biologic data more strongly support the hypothesis that antibiotic use is an indicator of infection and consequent inflammation, which may increase the risk of NHL, and that high cumulative NSAID use is a marker of chronic inflammation," they conclude. Am J Epidemiol 2005;162:965-974

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap